AAlyntStartup status intelligence
Explore
Enterprise AIConfidence BChinaactive

MindRank

Clinical-stage AI drug discovery company advancing machine-learning-designed therapeutics.

Official websitemindrank.ai
RegionHangzhou, China
CategoryEnterprise AI
Funding statusSeries A · Undisclosed
Last updatedJun 9, 2026
Latest signalJun 9, 2026
WebsiteSubmit correction

Status timeline

Funding, product, customer, team, and correction signals
Fact record
Apr 1, 2023Confidence A
Funding0 evidence links

MindRank capital or status signal reviewed

MindRank public source reviewed for capital or strategic-status timeline signal.

No source evidence matched to this event.
Apr 1, 2023Confidence A
Product0 evidence links

MindRank product scope reviewed

MindRank public product source reviewed for category placement and current operating focus.

No source evidence matched to this event.

Funding timeline

Amounts are shown only when disclosed and tied to evidence.
Fact record
Apr 1, 2023

Series A

AmountUndisclosed
InvestorsSherpa Healthcare Partners
EvidenceConfidence A
No source evidence matched to this round.

Source evidence

Public links, short factual summaries, and trust levels
Fact record

MindRank capital or status signal

MindRank · official
Confidence A

MindRank public capital or strategic-status source reviewed for stage and timeline signal.

Trust APublic review
Open source

MindRank official product profile

MindRank official site · official
Confidence A

MindRank official source reviewed for product scope, operating focus, and category placement.

Trust APublic review
Open source

Similar projects

Same category or overlapping tags
Discovery
METiS TherapeuticsSeries A · AI drug discovery, biotechGalixirUnknown · AI drug discovery, biotechDeepWiseStrategic · clinical AI, medical imagingBioMapSeries A · AI biotech, drug discovery